Increased government subsidies and ESG fund inflows are adding significant upside pressure to solar and wind operators. But not all of AngioDynamics's news was good. Sales grew 12% year over year, propelled by 26% growth in its med tech segment, but only 2% growth in medical devices. Despite earning 55.3% gross profit margins on these sales, though -- 90 basis points better than one year ago -- actual earnings as calculated according to generally accepted accounting principles ( GAAP ) were considerably worse than the $0.10 per-share "adjusted" profit noted above. Enter your email address below to receive the latest news and analysts' ratings for Energy Transfer and its competitors with MarketBeat's FREE daily newsletter. Analysts predict the stock price ET forecast for fintech firms will rise around 3.5%, boosted by payment system innovation and increased digital banking adoption rates worldwide.